Curet Myriam 4

What Happened

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, had restricted stock units (RSUs) and performance stock units (PSUs) convert to common stock on February 26, 2026. A total of vested/converted units included 3,052 and 1,602 share conversions plus a grant/award of 2,793 RSUs.
• To satisfy tax withholding obligations, 1,514 shares and 795 shares were withheld (disposed) at an effective price of $506.17 per share, totaling $766,341 and $402,405 respectively — about $1,168,746 in aggregate. The net shares were deposited into the holder’s account per the footnotes.
• These transactions are routine vesting/conversion and tax-withholding events rather than open-market sales or purchases.

Key Details

• Transaction date: February 26, 2026.
• Withheld (disposed) shares for tax: 1,514 @ $506.17 = $766,341; 795 @ $506.17 = $402,405. Total withheld value ≈ $1,168,746.
• Converted/acquired (derivative conversions or awards): 3,052 shares (conversion), 1,602 shares (conversion), and a grant/award of 2,793 RSUs (derivative).
• Shares owned after the transactions: Not disclosed in the provided Form 4 excerpt.
• Notable footnotes: RSUs vest per stated schedules (some vest 33% annually; some vest 100% on first anniversary). PSUs granted Feb 28, 2023 met performance criteria and vested on Feb 28, 2026. Portions of vested shares were held back to cover statutory tax withholding; net shares deposited to the holder’s account.
• Filing timeliness: Form filed Feb 27, 2026 reporting transactions on Feb 26, 2026 (no late filing indicated).

Context

• These filings reflect vesting/conversion of equity awards and a common "sell-to-cover" (share withholding) to satisfy tax obligations — not an open-market sale signaling a directional trade. For retail investors, purchases are generally more informative than routine vesting/tax-withholding events; here the material action is the recognition of vested equity and the associated tax withholding of ~2,309 shares.